Skip to main content

Equitable Financial Life Insurance Co Filed Unknown

First filed Feb 13, 2026 · CIK 727920

Effective prospectus: S-1/A Apr 21, 2026 (0001193125-26-165890) · terms unavailable

Offer price
Unavailable
Shares offered
Unavailable
Revenue (FY 2024)
$5.13B
Net income (FY 2024)
-$214M

What the company does

No publishable business summary is available from the effective-prospectus read.

Underwriters

Underwriters are unavailable because the effective-prospectus extraction was rejected.

Key risk factors

Risk factors are unavailable because the effective-prospectus extraction was rejected.

Financials before the first trade

Fiscal Year Revenue Growth YoY Gross Profit Gross Margin Operating Income Net Income Operating CF Cash Total Assets
FY 2024
ended 2024-12-31
$5.13B +45.9% -$214M $3.62B $1.62B $263.3B
FY 2023
ended 2023-12-31
$3.52B -49.7% $156M $1.37B $2.83B $263.09B
FY 2022
ended 2022-12-31
$6.98B +320.5% $1.6B -$1.72B $797M $227.42B
FY 2021
ended 2021-12-31
$1.66B -78.7% $1.11B -$1.37B $1.82B $270.96B
FY 2020
ended 2020-12-31
$7.79B +50.6% -$759M -$768M $251.29B
FY 2019
ended 2019-12-31
$5.17B -25.2% -$1.89B -$606M $1.49B $227.95B
FY 2018
ended 2018-12-31
$6.92B -18.0% -$899M $1.42B $2.62B $199.96B
FY 2017
ended 2017-12-31
$8.44B +39.6% $2.79B -$381M $2.4B $225.93B
FY 2016
ended 2016-12-31
$6.04B -32.3% $190M -$461M $1.94B $204.52B
FY 2015
ended 2015-12-31
$8.92B -34.5% $648M -$324M $2.47B $195.3B
FY 2014
ended 2014-12-31
$13.63B +380.1% $2.81B -$600M $2.72B $196.01B
FY 2013
ended 2013-12-31
$2.84B -69.0% -$3.57B $161M $2.28B $183.4B
FY 2012
ended 2012-12-31
$9.16B -48.7% $95M -$785M $3.16B $176.84B
FY 2011
ended 2011-12-31
$17.87B +56.2% $2.93B -$938M $3.23B $164.91B
FY 2010
ended 2010-12-31
$11.44B +252.9% $2.22B $6M $2.16B $161.28B
FY 2009
ended 2009-12-31
$3.24B -$2.3B $1.42B $1.79B

From the company's own XBRL-tagged financial statements (SEC companyfacts), full fiscal years only. Growth and margins are computed from the stated figures.

Filing history

Filed Form Accession
2026-04-21 S-1/A 0001193125-26-165890 View on EDGAR
2026-02-13 S-1 0001193125-26-050304 View on EDGAR